SHANGHAI: China's drug regulator has steeply raised the fees required to register drugs and medical devices in the world's second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process a rising number of applications.
"Handling drug and medical device applications and going through the process of examination and approval requires high costs in terms of man power and physical resources. This cost should be borne by the applicants," the regulator said.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!